Literature DB >> 1261038

Stereospecific distribution of fatty acids in human plasma triglycerides.

J Parijs, G A de Weerdt, R Beke, F Barbier.   

Abstract

Because of a biological difference between both primary hydroxylgroups of glycerol there are three distinct hydroxylgroups esterified with fatty acids in triglycerides. The distribution of fatty acids in the three distinct positions of triglycerides can be investigated by a combination of partial hydrolysis of triglycerides by pancreatic lipase, phosphorylation of the diglycerides formed and the stereospecific action of phospholipase A on phosphatides. Plasma triglycerides from normal and hyperlipemic humans are analysed. Human plasma triglycerides are highly asymmetric. The 1-position contains more than twice as much palmitic acid as the 3-position. Statistically significant differences are found between normal and hyperlipemic humans for palmitic and linoleic acid at the 2-position, and for oleic and linoleic acid at the 3-position.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1261038     DOI: 10.1016/0009-8981(76)90369-7

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  4 in total

1.  A model for studying LCAT reaction: in vitro cholesterol esterification in pig ovarian follicular fluid.

Authors:  J K Yao; S C Chang; R J Ryan; P J Dyck
Journal:  Lipids       Date:  1978-04       Impact factor: 1.880

2.  Triacylglycerol structure of plant and fungal oils containing ψ-linolenic acid.

Authors:  L D Lawson; B G Hughes
Journal:  Lipids       Date:  1988-04       Impact factor: 1.880

3.  Studies of triacyglycerol structure of very low density lipoproteins of normolipemic subjects and patients with type III and type IV hyperlipoproteinemia.

Authors:  J J Myher; A Kuksis; W C Breckenridge; J A Little
Journal:  Lipids       Date:  1984-09       Impact factor: 1.880

4.  Comparative studies of triacylglycerol structure of very low density lipoproteins and chylomicrons of normolipemic subjects and patients with type II hyperlipoproteinemia.

Authors:  J J Myher; A Kuksis; W C Breckenridge; V McGuire; J A Little
Journal:  Lipids       Date:  1985-02       Impact factor: 1.880

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.